TCL Archive Erbitux Plus Radiation, Chemo, Appears To Provide CRs In A Small Phase II Study February 23, 2007
TCL Archive Hammer Gives $100,000 to Expand Rosenberg’s T-Cell Growth Factor Clinical Studies March 1, 1985
TCL Archive Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies November 28, 2014